Q4 2024 Holdings
Filed 2025-02-14 | 58 holdings | $400.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $38.0M | 2,872,601 | 9.5% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $32.1M | 2,712,778 | 8.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $27.7M | 1,118,508 | 6.9% |
| Merus N V | COM | N5749R100 | $25.9M | 614,812 | 6.5% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $16.2M | 317,060 | 4.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $14.7M | 375,845 | 3.7% |
| Incyte Corp(INCY) | COM | 45337C102 | $13.4M | 193,623 | 3.3% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $12.0M | 416,968 | 3.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $11.9M | 584,328 | 3.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $11.6M | 208,016 | 2.9% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $11.4M | 145,234 | 2.8% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $10.8M | 641,964 | 2.7% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $10.3M | 134,178 | 2.6% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $9.4M | 166,068 | 2.3% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $8.9M | 721,209 | 2.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $8.5M | 193,535 | 2.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $8.4M | 992,803 | 2.1% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $7.8M | 145,876 | 1.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $7.4M | 106,610 | 1.8% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $7.2M | 166,307 | 1.8% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $7.0M | 949,401 | 1.8% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $7.0M | 61,403 | 1.7% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $7.0M | 500,966 | 1.7% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $7.0M | 186,413 | 1.7% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $5.9M | 2,328,492 | 1.5% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $5.5M | 141,714 | 1.4% |
| Acelyrin Inc | COM | 00445A100 | $5.4M | 1,704,825 | 1.3% |
| Surrozen Inc(SRZN) | COM NEW | 86889P208 | $5.0M | 350,573 | 1.3% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $4.9M | 400,101 | 1.2% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $4.5M | 428,137 | 1.1% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $4.3M | 579,500 | 1.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $4.3M | 101,809 | 1.1% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $4.3M | 545,800 | 1.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $3.9M | 83,576 | 1.0% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $3.9M | 265,833 | 1.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $3.5M | 132,706 | 0.9% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $3.4M | 270,983 | 0.9% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $2.9M | 135,244 | 0.7% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $2.6M | 126,400 | 0.6% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $2.2M | 96,716 | 0.5% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $2.1M | 200,900 | 0.5% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $1.8M | 332,394 | 0.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.6M | 90,000 | 0.4% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $1.5M | 150,000 | 0.4% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $1.3M | 28,136 | 0.3% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $1.3M | 47,642 | 0.3% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $725.7K | 200,475 | 0.2% |
| Arcutis Biotherapeutics Inc(ARQT)Call | COM | 03969K108 | $580.6K | 1,575,000 | 0.1% |
| Invesco QQQ TR(QQQ)Put | UNIT SER 1 | 46090E103 | $514.5K | 70,000 | 0.1% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $435.6K | 9,434 | 0.1% |